Charlson's weighted index of comorbidities is useful in assessing the risk of death in septic patients

Journal of Critical Care

Volumn 27, Issue 4, 2012, Pages 370-375

  Oltean, Simona ^a,b   Tatulescu, Doina ^a,b   Bondor, Cosmina ^a   Slavcovici, Adriana ^a,b   Cismaru, Cristina ^a,b   Lupşe, Mihaela ^a,b   Muntean, Monica ^a,b   Jianu, Cristian ^b   Marcu, Cristian ^a,b   Oltean, Mihai ^c,d  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Clinic of Infectious Diseases   (Romania)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Charlson's WIC; Comorbidities; Prognostic; Sepsis

Indexed keywords

ACCURACY; ADULT; ARTICLE; CALCULATION; CHARLON'S WEIGHTED INDEX OF COMORBIDITY; COMORBIDITY; DEATH; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEPSIS; SEPSIS RELATED ORGAN FAILURE ASSESSMENT; SURVIVAL RATE;

COMORBIDITY; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LOGISTIC MODELS; MALE; ORGAN DYSFUNCTION SCORES; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; SEPSIS; SHOCK, SEPTIC;

EID: 84864149224     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.08.021     Document Type: Article

References (35)

1. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885-891.
2. Karzai W., Reinhart K. Sepsis: definitions and diagnosis. Int J Clin Pract Suppl 1998, 95:44-48.
3. Dhainaut J.F., Claessens Y.E., Janes J., et al. Underlying disorders and their impact on the host response to infection. Clin Infect Dis 2005, 41:S481-S489.
4. Esper A.M., Moss M., Lewis C.A., et al. The role of infection and comorbidity: factors that influence disparities in sepsis. Crit Care Med 2006, 34:2576-2582.
5. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310.
6. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
7. Norena M., Wong H., Thompson W.D., et al. Adjustment of intensive care unit outcomes for severity of illness and comorbidity scores. J Crit Care 2006, 21:142-150.
8. D'Hoore W., Sicotte C., Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 1993, 32:382-387.
9. Poses R.M., McClish D.K., Smith W.R., et al. Prediction of survival of critically ill patients by admission comorbidity. J Clin Epidemiol 1996, 49:743-747.
10. Quach S, Hennessy DA, Faris P, et al. A comparison between the APACHE II and Charlson Index Score for predicting hospital mortality in critically ill patients. BMC Health Serv Res 2009, 9:129.
11. Sögaard M., Schönheyder H.C., Riis A., et al. Short-term mortality in relation to age and comorbidity in older adults with community-acquired bacteremia: a population-based cohort study. J Am Geriatr Soc 2008, 56:1593-1600.
12. Lesens O., Hansmann Y., Storck D., et al. Risk factors for metastatic infection in patients with Staphylococcus aureus bacteremia with and without endocarditis. Eur J Intern Med 2003, 14:227-231.
13. Yang Y., Yang K.S., Hsann Y.M., et al. The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis. J Crit Care 2010, 25:398-405.
14. Vincent J.L., Moreno R., Takala J., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
15. Jones A.E., Trzeciak S., Kline J.A. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 2009, 37:1649-1654.
16. Wang H., Ye L., Yu L., et al. Performance of sequential organ failure assessment, logistic organ dysfunction and multiple organ dysfunction score in severe sepsis within Chinese intensive care units. Anaesth Intensive Care 2011, 39:55-60.
17. Vosylius S., Sipylaite J., Ivaskevicius J. Sequential organ failure assessment score as the determinant of outcome for patients with severe sepsis. Croat Med J 2004, 45:715-720.
18. Hantke M., Holzer K., Thöne S., et al. The SOFA score in evaluating septic illnesses. Correlations with the MOD and APACHE II score. Chirurg 2000, 71:1270-1276.
19. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. Chest 1992, 101:1644-1655.
20. Munford R.S. Sepsis, severe sepsis and septic shock. Mandell, Douglas and Bennett's principles and practice of infectious diseases 2005, 919-921. Elsevier, Philadelphia. 6th ed. L. Mandell, J.E. Bennett, R. Dolin (Eds.).
21. Freid M.A., Vosti K.L. The importance of underlying disease in patients with gram-negative bacteremia. Arch Intern Med 1968, 121:418-423.
22. Pittet D., Thiévent B., Wenzel R.P., et al. Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med 1993, 19:265-272.
23. Brun-Buisson C., Doyon F., Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med 1996, 154:617-624.
24. Croce M.A., Fabian T.C., Waddle-Smith L., et al. Identification of early predictors for post-traumatic pneumonia. Am Surg 2001, 67:105-110.
25. Alberti C., Brun-Buisson C., Chevret S., et al. Systemic inflammatory response and progression to severe sepsis in critically ill infected patients. Am J Respir Crit Care Med 2005, 171:461-468.
26. Brun-Buisson C., Doyon F., Carlet J., et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA 1995, 274:968-974.
27. Rangel-Frausto M.S., Pittet D., Costigan M., et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 273:117-123.
28. Fried L., Bernardini J., Piraino B. Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis 2001, 37:337-342.
29. Albertsen P.C., Moore D.F., Shih W., et al. Impact of comorbidity on survival among men with localized prostate cancer. J Clin Oncol 2011, 29:1335-1341.
30. Kobayashi Y., Miura K., Hojo A., et al. Charlson comorbidity index is an independent prognostic factor among elderly patients with diffuse large B-cell lymphoma. J Cancer Res Clin Oncol 2011, 137:1079-1084.
31. Fedeli U., Schievano E., Buonfrate D., et al. Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect Dis 2011, 11:48.
32. Needham D.M., Scales D.C., Laupacis A., et al. A systematic review of the Charlson comorbidity index using Canadian administrative databases: a perspective on risk adjustment in critical care research. J Crit Care 2005, 20:12-19.
33. Deyo R.A., Cherkin D.C., Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45:613-961.
34. Tsai C.L., Lee C.C., Ma M.H., et al. Impact of diabetes on mortality among patients with community-acquired bacteremia. J Infect 2007, 55:27-33.
35. Thomsen R.W., Hundborg H.H., Lervang H.H., et al. Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study. Diabetes Care 2004, 27:70-76.